Archives for March 2007
Business 2.0 calls implantable devices one of “The Top-10 Products, Ideas and Trends” destined to shape the future. While pharma’s busy trying to cope with its dry-pipeline problem, “…companies like Boston Scientific, Medtronic, and an array of […]
21 March 2007 |
Blog |
According to a study released yesterday by the University of New Hampshire’s Center for Venture Research, angel investing is up (10.8 percent from 2005, to $25.6 billion last year) and medical devices are proving especially […]
20 March 2007 |
Blog |
San Francisco I-bank ThinkEquity Partners is out with its latest healthcare newsletter, and it’s rife with interesting tid bits. In public equity, ATS Medical, which makes cardiac surgery products, announced on March 16 that it […]
20 March 2007 |
Blog |
The Star Tribune ran a piece over the weekend about drug-device combos. It focused on Coon Rapids, Minnesota (a Minneapolis suburb)-based Possis Medical, a device company whose technologies focus on removing intra-vascular blood clots, and […]
19 March 2007 |
Blog |
Cepheid, a Sunnyvale, CA molecular diagnostics company, got the nod from FDA today to market a rapid test for meningitis that differentiates between viral and bacterial forms of the infection. The product, Xpert EV, is […]
19 March 2007 |
Blog |
PLC Medical Systems has enrolled the first patients in its FDA-approved clinical trial designed to evaluate the safety of its RenalGuard System. RenalGuard is an investigational therapy targeting patients with diminished renal function who may […]
19 March 2007 |
Blog |
Not being as closely scrutinized as the pharmaceutical industry has its advantages. But now the medical device industry wants a little attention. Industry insiders and lobbyists are concerned that the renewal of the Medical Device […]
16 March 2007 |
Blog |
A story in today’s The New York Times examines the issue of product-safety monitoring at medical device companies. The scope of the piece is limited in that it focuses almost exclusively on C.R. Bard subsidiary Davol, and […]
16 March 2007 |
Blog |
Spectranetics Corporation has stopped enrolling patients in the CELLO study after enrolling 61 of the planned 85 patients. Based on a review of the preliminary data, Spectranetics and FDA agreed that the clinical data from […]
16 March 2007 |
Blog |
TheStreet.com’s Dick Arms says, go short on Conceptus. He points out that the stock has built a top recently, opposed to going directly from an uptrend to a downtrend, which makes is shortable. “It broke support on volume, […]
15 March 2007 |
Blog |
